PROUROCARE MEDICAL INC

PROUROCARE MEDICAL INC

OOTC:PUMD
0.00
USD
0.00
(0.00%)
-0.11EPS
7.39MMarket Cap

Total Valuation

USD

As of September 30, 2013, PROUROCARE MEDICAL INC carries a market capitalization of 7.39M, placing it among publicly traded companies globally. Its enterprise value stands at 8.82M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap7.39M
Enterprise Value8.82M

Share Statistics

As of September 30, 2013, PROUROCARE MEDICAL INC has 18.47M shares outstanding.

Shares Outstanding18.47M

Valuation Ratios

These figures are as of September 30, 2013.

PB Ratio-1.78
P/TBV Ratio-1.78
P/FCF Ratio-11.01
P/OCF Ratio-11.01

Financial Position

As of September 30, 2013, PROUROCARE MEDICAL INC maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -34.53, indicating conservative leverage, while an interest coverage ratio of -3.56 demonstrates limited ability to service its debt obligations.

Current Ratio0.06
Debt / Equity-34.53
Debt / EBITDA-1.19
Interest Coverage-3.56

Financial Efficiency

These figures cover the twelve months ended September 30, 2013. Return on assets (ROA) is negative at -442.21, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 2.00, a quick read on workforce productivity versus industry peers.

Return on Assets (ROA)-442.21
Employee Count2.00

Stock Price Statistics

As of the close on October 1, 2026, PROUROCARE MEDICAL INC's stock has declined approximately 50.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

52-Week Price Change-50.00%

Income Statement

USD

Over the twelve months ended September 30, 2013, PROUROCARE MEDICAL INC generated - - in revenue and converted that into -2.11M in net income, yielding earnings per share of -0.11. EBITDA reached -1.21M, while operating income came in at -1.22M.

Operating Income-1.22M
Net Income-2.11M
EBITDA-1.21M
EBIT-1.22M
Earnings Per Share (EPS)-0.11

Balance Sheet

USD

As of September 30, 2013, PROUROCARE MEDICAL INC holds 970.00 in cash and equivalents against 1.43M in total debt, resulting in a net debt position of 1.43M. Total book value stands at -4.14M, with working capital of -3.73M providing operational flexibility.

Cash & Cash Equivalents970.00
Total Debt1.43M
Net Debt1.43M
Equity (Book Value)-4.14M
Book Value Per Share-0.22
Working Capital-3.73M

Cash Flow

USD

PROUROCARE MEDICAL INC produced -667,003.00 in operating cash flow over the twelve months ended September 30, 2013. After subtracting - - in capital expenditures, free cash flow totaled -667,003.00 - equivalent to -0.04 per share.

Operating Cash Flow-667,003.00
Free Cash Flow-667,003.00
FCF Per Share-0.04

Dividends & Yields

These figures cover the twelve months ended September 30, 2013. Free cash flow yield is negative at -9.09: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -9.43, meaning PROUROCARE MEDICAL INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-9.43
FCF Yield-9.09

Stock Splits

PROUROCARE MEDICAL INC's most recent stock split took place on February 21, 2008 with a 10:1 split ratio.

Last Split Date2/21/2008
Split Ratio10:1

Scores

As of September 30, 2013, PROUROCARE MEDICAL INC has an Altman Z-Score of -110.47, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-110.47